Chris Suharlim

Dr. Christian Suharlim is a medical doctor with experience providing primary health care in rural Indonesia. He has built expertise in health economics, particularly immunization, and is the technical lead on Pharmaceutical Financing and Resource Allocation for MTaPS. In addition to his current role, Dr. Suharlim represents USAID in the COVID-19 Vaccine Delivery Partnership working group, which supported alignment among stakeholders such as Gavi, UNICEF, and USAID and modeled the costs of delivering COVID-19 vaccination programs globally. He was on the WHO Vaccine Delivery Costing Expert Working Group, which developed a consensus statement on vaccine costing methods. Dr. Suharlim convenes the Immunization Economics Special Interest Group at the International Health Economics Association. He previously served as MSH’s Director of Economic Evaluation for a PHC costing project and also modeled the costs and benefits of investing in a new schistosomiasis drug in 36 countries for the Pediatric Praziquantel Consortium.

Dr. Suharlim received his MD from Universitas Indonesia, an MPH in health policy and management from the Harvard School of Public Health, and his postdoctoral fellowship from the Harvard Center for Health Decision Science.